首页基础医学药理学药理学 15 药理学 抗精神失常药.ppt

15 药理学 抗精神失常药.ppt

页数:33页文件大小:440.0 KB来源: 药理学ppt课件

本课件为药理学课程中的《抗精神失常药》,围绕抗精神失常药、SOME DEFINITIO、KEY CONCEPTS、KEY CONCE等部分展开,逐页梳理概念、机制与临床应用要点,适合预习、课堂对照与考前复习。

抗精神失常药封面页,标示本课件的主题与SOME DEFINITIO、KEY CONCEPTS、KEY CONCEPT等内容。
SOME DEFINITIONS,Neuroleptic: synonym for antipsychoticdrug; originally indicated drugw/antipsychotic efficacy but。
NEUROLEPTICS ON,THEUUHSC DRUG LIST TYPICAL NEUROLEPTICS: PHENOTHIAZINES: Chlorpromazine (Thorazine®) Thioridazine。
查看本课件的文字版(共 33 页,供检索与复制)

第1页:抗精神失常药

抗精神失常药 PHARMACOLOGY OFANTIPSYCHOTIC DRUGS(NEUROLEPTICS)

第2页:SOME DEFINITIONS

SOME DEFINITIONS

Neuroleptic: synonym for antipsychoticdrug; originally indicated drugw/antipsychotic efficacy but withneurologic (extrapyramidal motor) sideeffects

Typical neuroleptic: older agentsfitting this description

Atypical neuroleptic: newer agents:antipsychotic efficacy with reduced orno neurologic side effects

第3页:NEUROLEPTICS ON

  • NEUROLEPTICS ON THEUUHSC DRUG LIST
  • TYPICAL NEUROLEPTICS:
  • PHENOTHIAZINES:
  • Chlorpromazine (Thorazine®)
  • Thioridazine (Mellaril®)
  • Fluphenazine (Prolixin®)
  • THIOXANTHENE
  • Thiothixene (Navane®)
  • OTHER
  • Haloperidol (Haldol®)

第4页:NEUROLEPTICS ON THE

  • NEUROLEPTICS ON THE UUHSC DRUGLIST (Continued)
  • ATYPICAL NEUROLEPTICS:
  • Risperidone (Risperdal®; mostfrequently prescribed in U. S.)
  • Clozapine (Clozaril®)
  • Olanzapine (Zyprexa®)
  • Quetiapine (Seroquel®)

第5页:KEY CONCEPTS

KEY CONCEPTS:

All neurolepticsare equally effective in treatingpsychoses, including schizophrenia, but differ intheir tolerability.

All neurolepticsblock one or more types of DOPAMINEreceptor, but differ in their otherneurochemical effects.

All neurolepticsshow a significant delay before theybecome effective.

All neurolepticsproduce significant adverse effects.

第6页:GENERAL CHARACTERIST

GENERAL CHARACTERISTICS OFTYPICALNEUROLEPTICS

The older, typical neuroleptics are effectiveantipsychotic agents with neurologic sideeffects involving the extrapyramidal motorsystem.

Typical neuroleptics block the dopamine-2receptor.

第7页:GENERAL CHARACTERIST

GENERAL CHARACTERISTICS OFTYPICALNEUROLEPTICS

Typical neuroleptics do not produce ageneral depression of the CNS, e.g.respiratory depression

Abuse, addiction, physical dependencedo not develop to typical neuroleptics.

第8页:GENERAL CHARACTERIST

GENERAL CHARACTERISTICS OFTYPICALNEUROLEPTICS

Typical neuroleptics are generally moreeffective against positive (active)symptoms of schizophrenia than thenegative (passive) symptoms.

第9页:Positive/active

Positive/active symptomsincludethoughtdisturbances, delusions, hallucinations

Negative/passive symptomsincludesocialwithdrawal, loss of drive, diminishedaffect, paucity of speech. impairedpersonal hygiene

第10页:THERAPEUTIC EFFECTS

THERAPEUTIC EFFECTS OF TYPICALNEUROLEPTICS

All appear equally effective; choice usuallybased on tolerability of side effects

Most common are haloperidol (Haldol®),chlorpromazine (Thorazine®) and thioridazine(Mellaril®)

Latency to beneficial effects; 4-6 week delayuntil full response is common

70-80% of patients respond, but 30-40%show only partial response

第11页:THERAPEUTIC EFFECTS

  • THERAPEUTIC EFFECTS OF TYPICALNEUROLEPTICS (Continued)
  • Relapse, recurrence of symptoms iscommon ( approx. 50% within twoyears).
  • Noncompliance is common.
  • Adverse effects are common.

第12页:ADVERSE EFFECTS OF

  • ADVERSE EFFECTS OF TYPICALNEUROLEPTICS
  • Anticholinergic (antimuscarinic) sideeffects:
  • Dry mouth, blurred vision, tachycardia,constipation, urinary retention, impotence

第13页:ADVERSE EFFECTS OF

  • ADVERSE EFFECTS OF TYPICALNEUROLEPTICS
  • Antiadrenergic (Alpha-1) side effects:
  • Orthostatic hypotension w/ reflextachycardia
  • sedation

第14页:ADVERSE EFFECTS OF

  • ADVERSE EFFECTS OF TYPICALNEUROLEPTICS
  • Antihistamine effect: sedation, weightgain

第15页:KEY CONCEPT

  • KEY CONCEPT: DOPAMINE-2RECEPTOR BLOCKADE IN THE BASAL GANGLIARESULTS IN EXTRAPYRAMIDAL MOTOR SIDEEFFECTS (EPS).
  • DYSTONIA
  • NEUROLEPTIC MALIGNANTSYNDROME
  • PARKINSONISM
  • TARDIVE DYSKINESIA
  • AKATHISIA

第16页:ADVERSE EFFECTS OF

  • ADVERSE EFFECTS OF TYPICALNEUROLEPTICS (Continued)
  • Increased prolactin secretion (common with all;from dopamine blockade)
  • Weight gain (common, antihistamine effect?)
  • Photosensitivity (v. common w/ phenothiazines)
  • Lowered seizure threshold (common with all)
  • Leucopenia , agranulocytosis (rare; w/phenothiazines)
  • Retinal pigmentopathy (rare; w/ phenothiazines)

第17页:ADVERSE EFFECTS OF

ADVERSE EFFECTS OF TYPICALNEUROLEPTICS (Continued)

Chlorpromazineand thioridazine producemarked autonomic side effects and sedation;EPS tend to be weak (thioridazine) ormoderate (chlorpromazine).

Haloperidol, thiothixene and fluphenazineproduce weak autonomic and sedativeeffects, but EPS are marked.

第18页:

第19页:MECHANISMS OF

MECHANISMS OF ACTIONOF TYPICAL NEUROLEPTICS

DOPAMINE-2 receptor blockade inmeso-limbic and meso-cortical systemsfor antipsychotic effect.

DOPAMINE-2 receptor blockade in basalganglia (nigro-striatal system) for EPS

DOPAMINE-2 receptor supersensitivityin nigrostriatal system for tardivedyskinesia

第20页:LONG TERM EFFECTS OF

LONG TERM EFFECTS OF D2 RECEPTORBLOCKADE:

Dopamine neurons reduce activity.

Postsynaptic D-2 receptor numbers increase(compensatory response).

When D2 blockade is reduced, DA neuronsresume firing and stimulate increased # ofreceptors >> hyper-dopamine state >>tardive dyskinesia

第21页:MANAGEMENT OF EPS

  • MANAGEMENT OF EPS
  • Dystonia and parkinsonism: anticholinergicantiparkinson drugs
  • Neuroleptic malignant syndrome: musclerelaxants, DA agonists, supportive
  • Akathisia: benzodiazepines, propranolol
  • Tardive dyskinesia: increase neuroleptic dose;switch to clozapine

第22页:ADDITIONAL CLINICAL

  • ADDITIONAL CLINICAL USES OF TYPICALNEUROLEPTICS
  • Adjunctive in Rx of acute manic episode
  • Tourette’s syndrome (esp. Haldol®)
  • Rx of drug-induced psychoses
  • Phenothiazines are effective anti-emetics,
  • Esp. prochlorperazine (Compazine®)
  • Also, anti-migraine effect

第23页:

第24页:GENERAL CHARACTERIST

GENERAL CHARACTERISTICS OFATYPICAL NEUROLEPTICS

Effective antipsychotic agents with greatlyreduced or absent EPS, esp. reduced Parkinsonism and tardive dyskinesia

All atypical neuroleptics block dopamineandserotonin receptors; other neurochemicaleffects differ

Are effective against positiveandnegativesymptoms of schizophrenia;and in patientsrefractory to typical neuroleptics

第25页:PHARMACOLOGY

PHARMACOLOGY OFCLOZAPINE (CLOZARIL®)

FDA-approved for patients not responding toother agents or with severe tardivedyskinesia

Effective against negative symptoms

Also effective in bipolar disorder

Little or no parkinsonism, tardive dyskinesia, PRL elevation, neuro-malignant syndrome;some akathisia

第26页:Blockade of alpha-1

  • Blockade of alpha-1 adrenergicreceptors
  • Blockade of muscarinic cholinergicreceptors
  • Blockade of histamine-1 receptors

第27页:PHARMACOLOGY OF

  • PHARMACOLOGY OF CLOZAPINE(Continued )
  • Other adverse effects;
  • Weight gain
  • Increased salivation
  • Increased risk of seizures
  • Risk of agranulocytosis requirescontinual monitoring

第28页:PHARMACOLOGY OF

  • PHARMACOLOGY OF OLANZAPINE(ZYPREXA®)
  • Olanzapine is clozapine without theagranulocytosis.
  • Same therapeutic effectiveness
  • Same side effect profile

第29页:PHARMACOLOGY OF

  • PHARMACOLOGY OF QUETIAPINE(SEROQUEL®)
  • Quetiapine is olanzapine without theanticholinergic effects.
  • Same therapeutic effectiveness
  • Same side effect profile

第30页:Highly effective

  • Highly effective against positive andnegative symptoms
  • Adverse effects:
  • EPS incidence is dose-related
  • Alpha-1 receptor blockade
  • Little or no anticholinergic or antihistamineeffects
  • Weight gain, PRL elevation

第31页:HYPOTHESIZED

HYPOTHESIZED MECHANISMS OFACTION OF ATYPICAL NEUROLEPTICS

Combination of Dopamine-4 and Serotonin-2 receptor blockade in corticaland limbic areas for the“pines”

Combination of Dopamine-2 and Serotonin-2 receptor blockade (esp.risperidone)

第32页:General Therapeutic

  • General Therapeutic Principles for Use of Neuroleptics in Schizophrenia(NIH Consensus Statement, 1999)
  • Use atypical for:
  • 1st acute episode w/ + or +/-symptoms
  • Switch to atypical if:
  • Breakthrough after Rx w/ typical
  • Use typical (depot prep) when:
  • Patient is noncompliant

第33页:General Therapeutic

  • General Therapeutic Principles for Use of Neuroleptics in Schizophrenia
  • If response is inadequate to:
  • Typical; switch to Atypical
  • Atypical; raise dose or switch to another Atypical
  • Typical and Atypical; switch to Clozaril®
  • For maintenance, lifetime Rx is required.

《药理学》课件目录

顶部目录